U.S. Software Stock News

NYSE:LTC
NYSE:LTCHealth Care REITs

LTC Properties (LTC): Margin Decline Undermines Bullish Narratives Despite Strong Revenue Growth Forecasts

LTC Properties (LTC) reported net profit margins of 38.7% for the recent period, down from 47.6% a year ago, reflecting a notable decline in profitability. Over the past five years, the company’s earnings have grown 5.9% annually and are projected to increase by 6.47% per year going forward, which is well below the broader US market’s 16% forecasted annual growth. Investors may note that while LTC’s profit outlook trails the market, revenue is expected to climb 32.8% per year, which is...
NYSE:LYV
NYSE:LYVEntertainment

Live Nation (LYV): Profit Margins Jump, One-Off Loss Clouds Narrative for Bulls

Live Nation Entertainment (LYV) reported net profit margins of 2.3%, up from last year’s 1.1%, with EPS growth of 107.7% over the past year. That figure easily exceeds the company’s 5-year average annual earnings growth rate of 79.8%. Forecasts call for another 41.6% EPS growth per year going forward, ahead of the US market’s 16%. The company’s profitability streak and rising margins stand out, but a notable non-recurring loss of $412.7 million in the last twelve months adds complexity to the...
NasdaqGS:IDXX
NasdaqGS:IDXXMedical Equipment

Assessing IDEXX Laboratories After a 76% Rally and Surging Pet Healthcare Demand

Wondering whether IDEXX Laboratories is a bargain right now? Let's break down what today's price might mean for those looking for value or opportunity. Shares have soared by 14.7% in the past month and capped off an impressive 76.2% surge year-to-date, making it hard to ignore the stock's momentum and the shifting sentiment among investors. Much of the recent excitement can be traced to market buzz around continued strength in the animal diagnostics sector along with growing confidence in...
NasdaqGS:IREN
NasdaqGS:IRENSoftware

Should Investors Rethink IREN After Its 630% Rally and Microsoft Contract News?

Curious if IREN stock is the real deal or just another name catching headlines? Here is what investors should know before considering an investment. IREN has seen its share price increase by 26.5% in the past week and 630.5% year-to-date, indicating strong momentum and changing viewpoints on risk and opportunity. Some of this significant growth is linked to positive developments in the cryptocurrency and tech sectors, with IREN often noted in industry coverage as benefiting from rising...
NYSE:ZETA
NYSE:ZETASoftware

Zeta Global (ZETA) Revenue Growth Outpaces Market, Narrowing Losses Challenge Volatility Concerns

Zeta Global Holdings (ZETA) is forecasting revenue growth at an annual rate of 15.5%, outpacing the broader US market's 10.4% forecast. Despite remaining unprofitable and confirming ongoing negative margins, the company has trimmed its losses by 13% annually over the past five years, giving investors some optimism as shares hold steady near $19.94. See our full analysis for Zeta Global Holdings. Next, we will compare these headline statistics with the most widely discussed narratives about...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Clover Health (CLOV) Price-to-Sales Discount Challenges Skeptics as Profitability Forecast Strengthens

Clover Health Investments (CLOV) is currently unprofitable, but the company has managed to cut its losses by 25.5% per year over the past five years. Revenue is forecast to grow at 14.9% per year, outpacing the broader US market’s 10.4% growth rate. Meanwhile, earnings are expected to surge at an impressive 77.48% per year, with profitability anticipated within three years. While the share price has experienced volatility in recent months, investors are weighing the mix of swift growth and...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

Tarsus Pharmaceuticals (TARS): Losses Deepen 39.9% Annually, Bullish Growth Narrative Faces Profitability Test

Tarsus Pharmaceuticals (TARS) remains unprofitable, with annual losses having deepened at a rate of 39.9% per year over the past five years and no improvement in net profit margins in the latest period. Looking forward, revenue is forecast to grow 20.8% per year, outpacing the broader US market’s 10.5% growth. Earnings are projected to surge 115.27% annually, positioning the company for a potential move to profitability within the next three years. Investors watching Tarsus are weighing these...
NYSE:DD
NYSE:DDChemicals

Assessing DuPont’s Valuation Amid Leadership Changes and a 51% Share Price Drop

Curious about whether DuPont de Nemours offers fair value in today’s ever-changing market? You’re in the right place to dig deeper into what the numbers say about this well-known materials giant. The stock has seen some dramatic movement lately, with a sharp drop of over 51% in the last month but a solid gain of nearly 15% over the past year. This highlights both risks and longer-term gains for investors. Recent news stories have centered around leadership changes and ongoing portfolio...
NYSE:HLIO
NYSE:HLIOMachinery

Helios Technologies (HLIO): $31.1M One-Off Loss Challenges Bullish Margin Narratives

Helios Technologies (HLIO) posted a 12.2% annual decline in earnings over the past five years, with net profit margin slipping to 4.2% in the most recent period from 4.6% a year earlier. The results for the twelve months to 27th September 2025 included a significant one-off loss of $31.1 million that shaped overall profitability. Looking ahead, the company is forecast to deliver annual earnings growth of 24% for the next three years, which is higher than the broader US market's expected rate...
NasdaqGS:OUST
NasdaqGS:OUSTElectronic

Ouster (OUST) Revenue Forecast at 27.3% Annually Raises Margin Debate Ahead of Earnings

Ouster (OUST) is forecasting revenue growth at 27.3% per year, considerably ahead of the US market’s average 10.4% pace. Despite this top-line momentum, the company remains unprofitable, with losses having increased at an average rate of 9.4% annually over the past five years and a continued expectation of no profits for at least the next three years. Investors will likely weigh the strong growth outlook against the persistent losses and lack of margin improvement, especially given that...
NasdaqGS:GO
NasdaqGS:GOConsumer Retailing

Grocery Outlet (GO): Net Profit Margin Falls to 0.2%, Underscoring Margin Recovery Challenge

Grocery Outlet Holding (GO) posted net profit margins of 0.2%, down from 1.3% a year ago, with average annual earnings declines of 21.9% over the last five years. While results were dented by a one-off $69.6 million loss for the year ending September 27, 2025, management projects a robust rebound, forecasting EPS growth of 37.4% per year ahead. This projection is well above the US average of 16%. Investors will be watching closely to see if this projected earnings surge can offset recent...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

Palantir (PLTR) Profit Margin Surges, Reinforcing Bullish Narratives Despite Valuation Concerns

Palantir Technologies (PLTR) turned in a standout performance this quarter, posting net profit margins of 28.1% compared to 18% in the previous year and driving EPS higher in tandem with a massive 129.8% surge in earnings growth year over year. Analysts project revenue will increase at an annual rate of 26.7%, with profit growth forecasts even stronger at 29.2% per year for at least the next three years. With accelerating profits, expanding margins, and robust outlooks, investors are weighing...